Pharmaceutical cost containment and innovation in the United States

Author:

Kane Nancy M.

Publisher

Elsevier BV

Subject

Health Policy

Reference31 articles.

1. New drug development in the United States from 1963 to 1990;Di Masi;Clinical Pharmocology and Therapeutics,1991

2. Pricing, profits, and technological progress in the pharmaceutical industry;Scherer;Journal of Economic Perspectives,1993

3. Prescription drugs: spending controls in four European countries;United States General Accounting Office,1995

4. The role of the research-based pharmaceutical industry in medical progress in the United States;Kaitin;Health Care Policy,1993

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Medical Household Waste as a Potential Environmental Hazard: An Ecological and Epidemiological Approach;International Journal of Environmental Research and Public Health;2023-04-03

2. MANEJO DE RESIDUOS DE FÁRMACOS: UNA BREVE REVISIÓN;Revista Internacional de Contaminación Ambiental;2021-06-10

3. Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill;Archives of Internal Medicine;2009-04-27

4. Industry or academia: Who leads the research in medicine?;European Journal of Internal Medicine;2007-01

5. Prescription Drug Expenditures in the United States: The Effects of Obesity, Demographics, and New Pharmaceutical Products;Southern Economic Journal;2006-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3